Noticias de Eulerpool Castle Biosciences

Castle Biosciences Noticias de Acciones

Castle Biosciences es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de Castle Biosciences.

• 11 de junio ·

  Yahoo
  Castle Biosciences’ Chief Executive Officer Derek Maetzold to Participate in Panel Discussion During the 2025 BIO International Convention
• 4 de junio ·

  Yahoo
  Castle Biosciences’ Founder, President and CEO Derek Maetzold Honored with Prestigious Lifetime Achievement Award by The American Business Awards®
• 30 de mayo ·

  Yahoo
  Castle Biosciences, Inc. (CSTL) Unveils Largest Real-World Melanoma Risk Study at ASCO 2025
• 9 de mayo ·

  Yahoo
  Real-World Study Confirms Long-Term Performance of DecisionDx®-UM for Metastatic Risk Stratification in Uveal Melanoma and Utility of PRAME Biomarker for Refining Risk When Considered with the DecisionDx-UM Class Result
• 6 de mayo ·

  Yahoo
  Q1 2025 Castle Biosciences Inc Earnings Call
• 6 de mayo ·

  Yahoo
  Castle Biosciences Inc (CSTL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ...
• 28 de abril ·

  Yahoo
  DecisionDx®-Melanoma Test Ordered More Than 200,000 Times for Patients Diagnosed with Cutaneous Melanoma
• 7 de abril ·

  Yahoo
  Castle Biosciences Honored with a Top Workplaces USA Award for Fourth Consecutive Year
• 3 de abril ·

  Yahoo
  Publication of Data from Prospective, Multicenter Study Demonstrates Positive Survival Outcomes in Patients with Low-Risk Melanoma Who Avoided Sentinel Lymph Node Biopsy with Information from Castle Biosciences’ DecisionDx®-Melanoma Test
• 2 de abril ·

  Yahoo
  Are Castle Biosciences, Inc.'s (NASDAQ:CSTL) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?